Breast Carcinoma Amplified Sequence 2 (BCAS2) Peptid
BCAS2
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle BCAS2 Produkte
- BCAS2 (Breast Carcinoma Amplified Sequence 2 (BCAS2))
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- MAGTGLVAGE VVVDALPYFD QGYEAPGVRE AAAALVEEET RRYRPTKNYL
- Produktmerkmale
- A synthetic peptide for use as a blocking control in assays to test for specificity of BCAS2 antibody, catalog no. 70R-5000
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Buffer
- Lyophilized powder. Add 100 μL of distilled water for a final peptide concentration is 1 mg/mL.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 deg C long term. Avoid repeat freeze-thaw cycles.
-
- Target
- BCAS2 (Breast Carcinoma Amplified Sequence 2 (BCAS2))
- Synonyme
- DAM1 Peptide, SPF27 Peptide, Snt309 Peptide, 6430539P16Rik Peptide, AI132645 Peptide, C76366 Peptide, C80030 Peptide, BCAS2 Peptide, cb302 Peptide, zgc:101730 Peptide, BCAS2, pre-mRNA processing factor Peptide, breast carcinoma amplified sequence 2 Peptide, breast carcinoma amplified sequence 2 L homeolog Peptide, BCAS2 Peptide, Bcas2 Peptide, bcas2 Peptide, bcas2.L Peptide, CpipJ_CPIJ003889 Peptide
-
Sie sind hier:
